ClinicalTrials.Veeva

Menu

Establishment of Optimal Transfusion Threshold During Spine Surgery

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Spine Surgery
Anemia

Treatments

Other: Allowed drop in hemoglobin to level between 5,6-6,5 mmol/L
Other: Allowed drop in hemoglobin to level between 4,5-5,6 mmol/L

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00967109
H-C-2009-072

Details and patient eligibility

About

The purpose of this study is to determine whether a higher threshold for transfusion with red blood cells improves the tissue oxygenation.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Patients undergoing spine surgery
  • Be legally competent
  • Read and understand Danish

Exclusion criteria

  • Present malignant disease
  • Previously apoplexia cerebri
  • Known heart disease with functionality equivalent to NYHA II or CCS II or worse

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups

Allowed drop in hemoglobin to 4,5-5,5 mmol/L
Active Comparator group
Description:
Transfusion with red blood cells to level between 4.5-5.5 mmol/L
Treatment:
Other: Allowed drop in hemoglobin to level between 4,5-5,6 mmol/L
Allowed drop in hemoglobin to 5,5-6,5 mmol/L
Experimental group
Description:
Transfusion with red blood cells to level between 5.5-6.5 mmol/L
Treatment:
Other: Allowed drop in hemoglobin to level between 5,6-6,5 mmol/L

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems